In the intricate field of pharmaceutical synthesis, the quality and availability of precursor molecules are paramount. (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride, identified by CAS number 331763-59-8, stands out as a critical intermediate, playing a vital role in the creation of advanced therapeutic agents. Its typical appearance as an off-white to white solid or powder, coupled with a purity level of around 97%, makes it a reliable choice for rigorous synthetic processes.

The compound’s chemical structure, with the molecular formula C10H13Cl2NO2 and a molecular weight of 250.12 g/mol, provides a versatile scaffold for chemists. Its function as a GABA receptor agonist is a key area of interest, driving its use in research aimed at developing treatments for neurological disorders, including spasticity. Pharmaceutical companies that need to buy this compound for their R&D pipelines rely on manufacturers that can deliver consistent quality and adherence to specifications.

The synthesis of complex pharmaceutical compounds often involves multi-step pathways, and having access to well-characterized intermediates is crucial for efficiency and success. (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride serves as an excellent building block, allowing chemists to introduce specific functionalities or modify existing ones. For businesses looking to procure this chemical, partnering with established manufacturers, particularly those with strong capabilities in China, can provide a cost-effective and reliable supply chain.

When engaging with suppliers, it is important to inquire about bulk pricing and lead times, as well as the availability of detailed product documentation. A reputable manufacturer will not only supply the chemical but also offer technical support and assurances regarding quality control. This due diligence ensures that the purchased intermediate will perform as expected in downstream synthetic steps.

The demand for high-quality pharmaceutical intermediates continues to grow as the industry pushes the boundaries of drug discovery. Compounds like (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride are indispensable tools for researchers and manufacturers alike. By understanding its properties and the importance of reliable sourcing, pharmaceutical companies can effectively leverage this intermediate to accelerate their development programs.